Home›Grant Finder›Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
Sponsored by National Institutes of Health
Award
Varies — see funder site
Deadline
October 20, 2027
Geography
Open nationwide
Eligible organization types
Open to most organization types — confirm on funder site.